weight loss wegovy - Search News

News

Novo Nordisk launches weight-loss drug Wegovy

CNBC on MSN · 41m

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Reuters on MSN · 1d

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly began marketing its rival product Mounjaro in the world's most populous nation.

India TV News · 9h

Wegovy, Novo Nordisk's weight loss drug launched in India, check pricing and dosage

Wegovy is a GLP-1 receptor agonist that acts on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, improving satiety and reducing cravings for food, eventually inducing weight loss.

Novo Nordisk ends Wegovy sales on Hims & Hers

CBS News on MSN · 2d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Fast Company on MSN · 1d

Hims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff’ Wegovy

The breakup comes due to Novo Nordisk’s claims that Hims & Hers has ‘failed to adhere to the law’ by continuing to sell compounded versions of Wegovy. This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth company Hims & Hers Health (NYSE: HIMS),

The Wall Street Journal on MSN · 1d

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims’ compounding and deceptive marketing practices.

8hon MSN

Exclusive: New data show most US patients now stay on Wegovy, Zepbound after a year

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...

1don MSN

Monthly weight loss drug helps people lose 20% of body weight, trial finds

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results